“…The neonatal primary rat cardiomyocytes were divided into various experimental groups as follows: i) In the control group, cardiomyocytes were incubated under normal conditions for an additional 24 h; ii) in the sI/R group, cardiomyocytes were subjected to anoxia by incubating them in fresh anoxic medium [0.9 mM NaH 2 PO 4 , 6.0 mM NaHCO 3 , 1.8 mM CaCl 2 , 1.2 mM MgSO 4 , 40 mM sodium lactate, 20 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 98.5 mM NaCl, 10.0 mM KCl, pH 6.8; Sigma-Aldrich] at 37˚C in a chamber containing 95% N 2 and 5% CO 2 for 3 h. Subsequently, the medium was replaced with re-oxygenation medium (129.5 mM NaCl, 5.0 mM KCl, 0.9 mM NaH 2 PO 4 , 20 mM NaHCO 3 , 1.8 mM CaCl 2 , 1.2 mM MgSO 4 , 5.5 mM glucose, 20 mM HEPES, pH 7.4; Sigma-Aldrich) and the cells were incubated at 37˚C in an atmosphere of 95% air and 5% CO 2 for 2 h; iii) In the SQS+sI/R group, cells were pre-treated with SQS at 10 µM for 24 h prior to sI/R; iv) In the SQS+εV1-2+sI/R group, cells were pre-treated with εV1-2 (1 µM) and SQS (10 µM) for 24 h prior to sI/R. The doses of SQS and εV1-2 used were selected on the basis of a preliminary study by our group and previous reports (8,18,19).…”